DEMENTIAS - PowerPoint PPT Presentation

1 / 22
About This Presentation
Title:

DEMENTIAS

Description:

Alzheimers. Memory, Language, Visuospatial, Indifferent to Loss. Frontotemporal (Picks) ... Alzheimer's Disease and Related Disorders, Medical Clinics of NA May 2001. ... – PowerPoint PPT presentation

Number of Views:38
Avg rating:3.0/5.0
Slides: 23
Provided by: patrici90
Category:

less

Transcript and Presenter's Notes

Title: DEMENTIAS


1
DEMENTIAS
  • Pat Borman, MD
  • Director Advanced Training in Geriatrics

2
GOALS IN DEMENTIA
  • Evaluation and Diagnosis
  • Current Therapy for Dementia
  • Complications
  • Resources for the Caregivers

3
DEFINITION OF DEMENTIA
  • MEMORY IMPAIRMENT
  • AND One or more
  • APHASIA APRAXIA
  • AGNOSIA VISUOSPATIAL
  • LOSS OF EXECUTIVE FUNCTION
  • Gradual, Progressive, Impairs function social,
    job, family, no other explainations

4
TYPES OF DEMENTIA
  • Alzheimers
  • Memory, Language, Visuospatial, Indifferent to
    Loss
  • Frontotemporal (Picks)
  • Memory, Marked Personality changes, Preserved
    visuospatial
  • Lewey Body
  • Visual hallucinations, delusions, flucutating
    mental status

5
TYPES OF DEMENTIA
  • Parkinsons Disease
  • 15-30 develop dementia
  • Vascular Dementia
  • Progressive Supranuclear Palsy
  • The Rare Birds
  • Late onset Metobolic Disease
  • Creutzfeld-Jacob

6
EVALUATION
  • HISTORY
  • HPI, Medical, Medications, Psychiatric,
    Functional, Caregiver
  • EXAM
  • Physical, Neurologic, Psychiatric, Cognitive
    Testing

7
EVALUATION
  • LABORATORY
  • Blood Work
  • CBC, TSH, Chem 7, Ca 2, B12, Folate
  • RPR
  • Imaging
  • CT or MRI
  • Other Studies
  • LP, neuropsychiatric testing, EEG,
  • SPECT, PET

8
DIFFERENTIAL DIAGNOSIS
  • DEPRESSION Pseudodementia
  • CNS Neoplasm, NPH, stroke
  • Vascular subdural, vasculitis,
  • Endocrine Thyroid, Calcium,
  • Nutritional B12, Thiamine,ETOH
  • Infections HIV, Cryptococcus

9
CURRENT THERAPY
  • CHOLINESTERASE INHIBITORS
  • For mild to moderate disease, slow progression,
    stabilize ADL and MMSE
  • 1st Generation
  • Tacrine hepatotoxic, last choice
  • 2nd Generation
  • Donepezil 5-10 mg qd 113/mp
  • Rivastigmine 3-6 mg bid 153/mo
  • Galantamine 16-32 298/mo

10
CURRENT THERAPY
  • VITAMIN E
  • Antioxident, inexpensive
  • GINKGO BILOBA
  • Antioxident, anti-inflammatory
  • ESTROGENS
  • neuroprotective?
  • NSAIDS
  • Epidemiologic suggestions

11
COMPLICATIONS
  • Depression 40
  • Suspicion 30
  • Disinhibition 50
  • Agitation 50
  • Verbal, Vocal,
  • Motor
  • Psychosis
  • Hallucinations15
  • Delusions 30
  • Anxiety 40
  • Aggression 30
  • Withdrawal 40
  • Vegetative
  • sleep 90
  • appetite 30
  • Wandering 60
  • Apathy 60

12
APPROACHES TO BEHAVIOR PROBLEMS
  • 1. Define target symptoms
  • 2. Revisit medical diagnoses
  • 3. Establish neuropsychiatric diagnoses
  • 4. Assess and remove provoking factors
  • environmental, psychosocial, other
  • 5. Adapt environment and treatments to specific
  • cognitive deficits
  • 6. Educate caregivers
  • 7. Employ behavior management principles
  • 8. Treat specific psychiatric disease
    specifically
  • 9. For remaining behavior problems consider
  • symptomatic pharmacotherapy

13
PHARMACOTHERAPY
  • DEPRESSION
  • SSRIS Paroxetine, Sertraline, Others
  • TCADS Nortriptyline
  • ECT if life threatening
  • ANXIETY
  • Buspirone,Lorazepam, Propanolol
  • PSYCHOSIS
  • Rispiridone, Olanzepine, Haloperidol

14
PHARMACOTHERAPY
  • Aggression
  • Trazedone, Buspirone, Olanzepine, Others
  • Agitation
  • Haloperidol, Lorazepam, Trazedone, Carbamazepine
  • Insomnia
  • Melatonin, Benzodiazepines, Trazedone
  • Sundowning
  • Trazedone, Haloperidol, Risperidone, Olanzepine

15
PROGRESSION
  • Forgetfulness
  • complains of memory deficits, misplace objects,
    trouble word finding, functional
  • Confusional
  • getting lost, job trouble, language problems,
    lost objects, denial, anxiety, lost current
    events, cant handle finances other executive
    functions, withdrawal
  • Early Dementia
  • Need assistance, cant use phone reliably,
    disorentation to time, place, know family, can
    feed and toilet with reminders

16
PROGRESSION
  • Middle Dementia
  • Unaware of surroundings, forget spouses name,
    loss of recent events of life, personality and
    behavior changes, needs help with most ADL
  • Late Dementia
  • Loss of all verbal abilities, complete
    incontinence, no thirst or hunger responses
  • TIME COURSE

17
DAY TO DAY CARE
  • Be Firm, Dont Rush or Argue
  • Now it time to.., dont rush or argue
  • Minimize Distractions
  • Decrease noise, remove visual clutter
  • Keep It Simple, Keep It Safe
  • Cannot follow multi-step commands
  • Lower Your Standards
  • Expect less from the patient
  • Establish Routines
  • Reassuring, reduce agitation

18
Day to Day Care
  • Alzheimers Association
  • 1-800-848-9707 www.alza.org
  • Washington Adult Day Care Assoc
  • 206-461-3899 www.adultday.org
  • Senior Information and Assistance
  • 206-448-3110 www.seniorservice.org

19
CARE FOR CAREGIVERS
  • Information about progression
  • Facilitate Day-to-Day Care
  • Stress Reduction Skills
  • Support
  • Risk for depression, illness, fatigue, elder
    abuse
  • How to know when you can no longer provide care
    at home

20
CARE GIVER SUPPORT
  • Alzheimers and Related Disorders Association
  • 1-800-272-3900
  • Alzheimers Disease Education and Referral Center
  • 1-800-438-4380
  • www.alzheimers.org/adear
  • Family Caregiver Alliance
  • 1-800-445-8160
  • www.caregiver.org

21
Economics of Dementia
  • 2-5 million affected
  • With current demographics 10 million by 2030
  • Expenses TOTAL 100 Billion
  • Ranks third (Heart disease and Cancer)
  • Per Capita
  • Direct 10-25K home, 40-50k NH
  • Indirect 60k
  • Unpaid Care 10-50k
  • Paid Out of Pocket 65

22
REFERENCES
  • Small, GW et.al. Diagnosis and Treatment of
    Alzheimer Disease and Related Disorders, JAMA
    Oct 1997.
  • Raskind MA, Peskind ER. Alzheimers Disease and
    Related Disorders, Medical Clinics of NA May
    2001.
  • Alzheimers Disease The Reality and the Promise,
    Patient Care Nov 1996. (Entire issue devoted to
    this topic.)
  • Fillit H, Cummings J. Practice Guidelines for the
    Diagnosis and Treatmentof Alzheimers Disease in a
    Managed Care Setting Part I and II, Managed Care
    Interface Dec 1999.
  • Tariot PN et. al. Treating Aggression in Patients
    witrh Dementia, Medical Education Collaborative
    and ABComm May 2000.
  • Practical Alheimers Disease Management A
    ComparativeReview of New Compounds, Diasnosis,
    Treatment and Outcomes Assessment, Post Graduate
    Medicine May 1999.
Write a Comment
User Comments (0)
About PowerShow.com